Market closedNon-fractional

TG Therapeutics/TGTX

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About TG Therapeutics

Ticker

TGTX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Morrisville, United States

Employees

284

TG Therapeutics Metrics

BasicAdvanced
$2.6B
Market cap
65.56
P/E ratio
$0.28
EPS
2.32
Beta
-
Dividend rate
$2.6B
2.32
3.617
2.756
68.882
69.253
4.01%
10.59%
43.93%
65.56
9.08
16.19
16.27
129.48
3,275.33%
-122.68%
583.28%
-52.55%

What the Analysts think about TG Therapeutics

Analyst Ratings

Majority rating from 9 analysts.
Buy

TG Therapeutics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-16.87% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$63M
44.42%
Net income
-$11M
-25.69%
Profit margin
-16.87%
-48.57%

TG Therapeutics Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 96.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.34
$0.73
-$0.10
-$0.07
-
Expected
-$0.25
$0.12
-$0.10
-$0.04
-$0.05
Surprise
36.68%
530.87%
-4.11%
96.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for TG Therapeutics stock?

TG Therapeutics (TGTX) has a market cap of $2.6B as of July 04, 2024.

What is the P/E ratio for TG Therapeutics stock?

The price to earnings (P/E) ratio for TG Therapeutics (TGTX) stock is 65.56 as of July 04, 2024.

Does TG Therapeutics stock pay dividends?

No, TG Therapeutics (TGTX) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next TG Therapeutics dividend payment date?

TG Therapeutics (TGTX) stock does not pay dividends to its shareholders.

What is the beta indicator for TG Therapeutics?

TG Therapeutics (TGTX) has a beta rating of 2.32. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell TG Therapeutics stock

Buy or sell TG Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing